Epidemiology, Clinical Characteristics, and Outcomes of a Large Cohort of COVID-19 Outpatients in Michigan.
COVID-19
SARS-CoV-2
demographics
epidemiology
infectious disease
outpatient
Journal
International journal of general medicine
ISSN: 1178-7074
Titre abrégé: Int J Gen Med
Pays: New Zealand
ID NLM: 101515487
Informations de publication
Date de publication:
2021
2021
Historique:
received:
04
02
2021
accepted:
15
03
2021
entrez:
6
5
2021
pubmed:
7
5
2021
medline:
7
5
2021
Statut:
epublish
Résumé
Most outpatients with coronavirus disease 2019 (COVID-19) do not initially demonstrate severe features requiring hospitalization. Understanding this population's epidemiological and clinical characteristics to allow outcome anticipation is crucial in healthcare resource allocation. Retrospective, multicenter (8 hospitals) study reporting on 821 patients diagnosed with COVID-19 by real-time reverse transcriptase-polymerase chain reaction assay of nasopharyngeal swabs and discharged home to self-isolate after evaluation in emergency departments (EDs) within Beaumont Health System in March, 2020. Outcomes were collected through April 14, 2020, with a minimum of 12 day follow-up and included subsequent ED visit, admission status, and mortality. Of the 821 patients, mean age was 49.3 years (SD 15.7), 46.8% were male and 55.1% were African-American. Cough was the most frequent symptom in 78.2% of patients with a median duration of 3 days (IQR 2-7), and other symptoms included fever 62.1%, rhinorrhea or nasal congestion 35.1% and dyspnea 31.2%. ACEI/ARBs usage was reported in 28.7% patients and 34.0% had diabetes mellitus. Return to the ED for re-evaluation was reported in 19.2% of patients from whom 54.4% were admitted. The patients eventually admitted to the hospital were older (mean age 54.4 vs 48.7 years, We found that 80.8% of patients did not return to the ED for re-evaluation. Sending patients with COVID-19 home if they experience mild symptoms is a safe approach for most patients and might mitigate some of the financial and staffing pressures on healthcare systems.
Sections du résumé
BACKGROUND
BACKGROUND
Most outpatients with coronavirus disease 2019 (COVID-19) do not initially demonstrate severe features requiring hospitalization. Understanding this population's epidemiological and clinical characteristics to allow outcome anticipation is crucial in healthcare resource allocation.
METHODS
METHODS
Retrospective, multicenter (8 hospitals) study reporting on 821 patients diagnosed with COVID-19 by real-time reverse transcriptase-polymerase chain reaction assay of nasopharyngeal swabs and discharged home to self-isolate after evaluation in emergency departments (EDs) within Beaumont Health System in March, 2020. Outcomes were collected through April 14, 2020, with a minimum of 12 day follow-up and included subsequent ED visit, admission status, and mortality.
RESULTS
RESULTS
Of the 821 patients, mean age was 49.3 years (SD 15.7), 46.8% were male and 55.1% were African-American. Cough was the most frequent symptom in 78.2% of patients with a median duration of 3 days (IQR 2-7), and other symptoms included fever 62.1%, rhinorrhea or nasal congestion 35.1% and dyspnea 31.2%. ACEI/ARBs usage was reported in 28.7% patients and 34.0% had diabetes mellitus. Return to the ED for re-evaluation was reported in 19.2% of patients from whom 54.4% were admitted. The patients eventually admitted to the hospital were older (mean age 54.4 vs 48.7 years,
CONCLUSION
CONCLUSIONS
We found that 80.8% of patients did not return to the ED for re-evaluation. Sending patients with COVID-19 home if they experience mild symptoms is a safe approach for most patients and might mitigate some of the financial and staffing pressures on healthcare systems.
Identifiants
pubmed: 33953603
doi: 10.2147/IJGM.S305295
pii: 305295
pmc: PMC8089468
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1555-1563Informations de copyright
© 2021 Halalau et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
JAMA. 2020 Apr 14;323(14):1339-1340
pubmed: 32108857
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1899-1913
pubmed: 32912793
J Intern Med. 2020 Oct;288(4):469-476
pubmed: 32498135
Lancet. 2020 Feb 15;395(10223):473-475
pubmed: 32043983
J Intern Med. 2020 Sep;288(3):335-344
pubmed: 32352202
Circ Res. 2020 Jun 5;126(12):1671-1681
pubmed: 32302265
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Am J Med. 2021 Jan;134(1):16-22
pubmed: 32771461
J Med Virol. 2020 Apr;92(4):433-440
pubmed: 31967321
Vascul Pharmacol. 2020 Dec;135:106805
pubmed: 32992048
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Nat Rev Gastroenterol Hepatol. 2020 May;17(5):259
pubmed: 32214231
Mediterr J Hematol Infect Dis. 2020 Sep 01;12(1):e2020063
pubmed: 32952974
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Vector Borne Zoonotic Dis. 2020 Dec;20(12):910-915
pubmed: 33054699
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
Am Fam Physician. 2020 Oct 15;102(8):478-486
pubmed: 33064422
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
J Card Fail. 2020 May;26(5):370
pubmed: 32439095